Found: 40
Select item for more details and to access through your institution.
Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05795-3
- By:
- Publication type:
- Article
c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 8, p. 12628, doi. 10.1002/jcb.28529
- By:
- Publication type:
- Article
Complete Blood Count Score Model Integrating Reduced Lymphocyte‐Monocyte Ratio, Elevated Neutrophil‐Lymphocyte Ratio, and Elevated Platelet‐Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T‐Lymphoblastic Lymphoma.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1123, doi. 10.1634/theoncologist.2018-0789
- By:
- Publication type:
- Article
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12032-9
- By:
- Publication type:
- Article
DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T‐cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 405, doi. 10.1111/cts.12893
- By:
- Publication type:
- Article
Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 7189, doi. 10.2147/OTT.S262039
- By:
- Publication type:
- Article
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923829
- By:
- Publication type:
- Article
Increased expression of microRNA-503 and reduced expression of kangai-1 in B-cell non-Hodgkin's lymphoma.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 3, p. 917, doi. 10.3892/etm.2016.2971
- By:
- Publication type:
- Article
A randomized controlled study of bedside electrocardiograph-guided tip location technique & the traditional chest radiography tip location technique for peripherally inserted central venous catheter in cancer patients.
- Published in:
- Indian Journal of Medical Research, 2018, v. 147, n. 5, p. 477, doi. 10.4103/ijmr.IJMR_1120_16
- By:
- Publication type:
- Article
Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: Two case reports and a literature review.
- Published in:
- Oncology Letters, 2018, v. 16, n. 5, p. 6624, doi. 10.3892/ol.2018.9447
- By:
- Publication type:
- Article
Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.
- Published in:
- Oncology Letters, 2018, v. 16, n. 1, p. 1275, doi. 10.3892/ol.2018.8783
- By:
- Publication type:
- Article
Penile metastasis secondary to nasal-type extranodal natural killer/T-cell lymphoma: A case report and review of the literature.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemia.
- Published in:
- Oncology Letters, 2016, v. 12, n. 5, p. 4173, doi. 10.3892/ol.2016.5163
- By:
- Publication type:
- Article
Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma.
- Published in:
- Oncology Letters, 2016, v. 11, n. 1, p. 693, doi. 10.3892/ol.2015.3950
- By:
- Publication type:
- Article
Natural killer/T-cell lymphoma-associated hemophagocytic syndrome: A case report.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2019, v. 9, p. 33, doi. 10.2147/BLCTT.S216292
- By:
- Publication type:
- Article
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis‐like T‐cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 772, doi. 10.1111/bjh.14763
- By:
- Publication type:
- Article
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0644-6
- By:
- Publication type:
- Article
Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. 1, doi. 10.3389/fcimb.2021.686595
- By:
- Publication type:
- Article
Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on <sup>18</sup>F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 3, p. 837, doi. 10.4143/crt.2020.123
- By:
- Publication type:
- Article
Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 11, p. 1889, doi. 10.1007/s00277-014-2136-7
- By:
- Publication type:
- Article
AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma.
- Published in:
- Molecular Medicine, 2018, v. 24, n. 1, p. N.PAG, doi. 10.1186/s10020-018-0033-6
- By:
- Publication type:
- Article
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026
- By:
- Publication type:
- Article
Research on chemotherapy efficacy of twist gene on cervical cancer cells to paclitaxel.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2014, v. 27, n. 5, p. 1713
- By:
- Publication type:
- Article
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 427, doi. 10.1007/s11060-018-2970-x
- By:
- Publication type:
- Article
Clinical analysis of patients with primary and secondary extranodal natural killer/T‐cell lymphoma of central nervous system.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 2, p. 267, doi. 10.1002/hon.2894
- By:
- Publication type:
- Article
Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8134, doi. 10.1002/cam4.5615
- By:
- Publication type:
- Article
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.687374
- By:
- Publication type:
- Article
Clinical features and prognostic factors of primary bone marrow lymphoma.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 2553, doi. 10.2147/CMAR.S187522
- By:
- Publication type:
- Article
Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 1363, doi. 10.2147/CMAR.S192143
- By:
- Publication type:
- Article
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0559-7
- By:
- Publication type:
- Article
The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3449, doi. 10.1007/s00432-022-04203-x
- By:
- Publication type:
- Article
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.
- Published in:
- Drug Design, Development & Therapy, 2020, v. 14, p. 275, doi. 10.2147/DDDT.S227477
- By:
- Publication type:
- Article
Quercetin Potentiates the Antitumor Activity of Rituximab in Diffuse Large B-Cell Lymphoma by Inhibiting STAT3 Pathway.
- Published in:
- Cell Biochemistry & Biophysics, 2014, v. 70, n. 2, p. 1357, doi. 10.1007/s12013-014-0064-8
- By:
- Publication type:
- Article
Utility of baseline, interim and end-of-treatment <sup>18</sup>F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.
- Published in:
- Scientific Reports, 2017, p. 41057, doi. 10.1038/srep41057
- By:
- Publication type:
- Article
S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.
- Published in:
- Scientific Reports, 2016, p. 23695, doi. 10.1038/srep23695
- By:
- Publication type:
- Article
Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 6, p. 1470, doi. 10.1002/ijc.33329
- By:
- Publication type:
- Article